Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Concomitant immunity and specific depression of immunity by residual or reinjected syngeneic tumor tissue.

× No keyword cloud information.

13 in total

1. Interleukin-17D mediates tumor rejection through recruitment of natural killer cells.

Authors: Timothy O'Sullivan; Robert Saddawi-Konefka; Emilie Gross; Miller Tran; Stephen P Mayfield; Hiroaki Ikeda; Jack D Bui
Journal: Cell Rep Date: 2014-05-01 Impact factor: 9.423

Review 2. Tumor dormancy: a review.

Authors: E A Alsabti
Journal: J Cancer Res Clin Oncol Date: 1979 Impact factor: 4.553

3. Tumour-associated antigens.

Authors: R W Baldwin
Journal: Z Krebsforsch Klin Onkol Cancer Res Clin Oncol Date: 1977-05-20

4. The therapeutic significance of concomitant antitumor immunity. I. LY-1-2+ T cells from mice with a progressive tumor can cause regression of an established tumor in gamma-irradiated recipients.

Authors: R J North
Journal: Cancer Immunol Immunother Date: 1984 Impact factor: 6.968

Review 5. Modulation of antitumor immunity--immunobiologic approaches.

Authors: R J North; E S Dye; C D Mills; J P Chandler
Journal: Springer Semin Immunopathol Date: 1982

6. T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor.

Authors: M J Berendt; R J North
Journal: J Exp Med Date: 1980-01-01 Impact factor: 14.307

7. Inhibition of human renal cancer by monoclonal-anti-body-linked methotrexate in an ascites tumor model.

Authors: M Singh; T Ghose; J Kralovec; A H Blair; P Belitsky
Journal: Cancer Immunol Immunother Date: 1991 Impact factor: 6.968

8. "Concomitant immunity" in murine tumours of non-detectable immunogenicity.

Authors: R A Ruggiero; O D Bustuoabad; R D Bonfil; R P Meiss; C D Pasqualini
Journal: Br J Cancer Date: 1985-01 Impact factor: 7.640

9. T-cell-mediated concomitant immunity to syngeneic tumors. I. Activated macrophages as the expressors of nonspecific immunity to unrelated tumors and bacterial parasites.

Authors: R J North; D P Kirstein
Journal: J Exp Med Date: 1977-02-01 Impact factor: 14.307

10. Subversion of host defense mechanisms by malignant tumors: an established tumor as a privileged site for bacterial growth.

Authors: G L Spitalny; R J North
Journal: J Exp Med Date: 1977-05-01 Impact factor: 14.307